StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.18−0.01 (-3.02%)

Close on Nov 18, 2026Market cap $2.50MP/E –Yield –

VolitionRx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

VolitionRx's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.56M. For fiscal 2025 it was -$19.68M. The highest annual figure on record is -$1.65M in fiscal 2011.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$19.68M–
FY2024Dec 31, 2024-$25.89M–
FY2023Dec 31, 2023-$18.06M–
FY2022Dec 31, 2022-$15.28M–
FY2021Dec 31, 2021-$20.85M–
FY2020Dec 31, 2020-$16.46M–
FY2019Dec 31, 2019-$12.74M–
FY2018Dec 31, 2018-$14.73M–
FY2017Dec 31, 2017-$12.19M–
FY2016Dec 31, 2016-$8.86M–
FY2015Dec 31, 2015-$8.55M–
FY2014Dec 31, 2014-$4.14M–
FY2013Dec 31, 2013-$3.08M–
FY2012Dec 31, 2012-$2.31M–
FY2011Dec 31, 2011-$1.65M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.16M–
Q1 FY2026Mar 31, 2026-$5.28M–
Q4 FY2025Dec 31, 2025-$5.49M–
Q3 FY2025Sep 30, 2025-$3.63M–
Q2 FY2025Jun 30, 2025-$6.26M–
Q1 FY2025Mar 31, 2025-$4.30M–
Q4 FY2024Dec 31, 2024-$5.43M-184.2%
Q3 FY2024Sep 30, 2024-$5.39M–
Q2 FY2024Jun 30, 2024-$6.73M–
Q1 FY2024Mar 31, 2024-$8.34M–
Q4 FY2023Dec 31, 2023$6.45M–
Q3 FY2023Sep 30, 2023-$8.42M–
Q2 FY2023Jun 30, 2023-$7.35M–
Q1 FY2023Mar 31, 2023-$8.74M-342.2%
Q4 FY2022Dec 31, 2022-$5.80M–
Q3 FY2022Sep 30, 2022-$6.82M–
Q2 FY2022Jun 30, 2022-$6.27M–
Q1 FY2022Mar 31, 2022$3.61M–
Q4 FY2021Dec 31, 2021-$4.41M–
Q3 FY2021Sep 30, 2021-$4.88M–
Q2 FY2021Jun 30, 2021-$5.40M–
Q1 FY2021Mar 31, 2021-$6.17M–
Q4 FY2020Dec 31, 2020-$2.73M–
Q3 FY2020Sep 30, 2020-$4.50M–
Q2 FY2020Jun 30, 2020-$4.43M–
Q1 FY2020Mar 31, 2020-$4.80M–
Q4 FY2019Dec 31, 2019-$2.60M–
Q3 FY2019Sep 30, 2019-$3.72M–
Q2 FY2019Jun 30, 2019-$2.77M–
Q1 FY2019Mar 31, 2019-$3.65M–
Q4 FY2018Dec 31, 2018-$3.63M–
Q3 FY2018Sep 30, 2018-$4.61M–
Q2 FY2018Jun 30, 2018-$2.98M–
Q1 FY2018Mar 31, 2018-$3.51M–
Q4 FY2017Dec 31, 2017-$3.89M–
Q3 FY2017Sep 30, 2017-$2.82M–
Q2 FY2017Jun 30, 2017-$2.81M–
Q1 FY2017Mar 31, 2017-$2.67M–
Q4 FY2016Dec 31, 2016-$2.19M–
Q3 FY2016Sep 30, 2016-$2.11M–

More VolitionRx figures

See a number that looks wrong?